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Most of the complications associated to bronchoscopy are related to changes of the
respiratory function during or after its performance. Prevention of complications should be
achieved by understanding the effects of bronchoscopic procedures and their relation to
the pulmonary function deterioration. Previous studies regarding the functional impair-
ment caused by bronchoalveolar lavage (BAL) were mostly limited by the presence of
interferent factors such as sedative drugs. Furthermore, it is not clear whether or not
patients with different ventilatory disturbances present the same functional response to
bronchoscopy and BAL.
The aim of this study was to determine the additional effects of BAL over the respiratory
function deterioration related to bronchoscopy in patients with different respiratory
function profiles (normal, restrictive and obstructive).
Forty patients submitted to bronchoscopy without premedication were divided into four
groups: group I—normal pulmonary function submitted to basic bronchoscopy; group
II—bronchoscopy in combination with BAL, subdivided according to pulmonary function:
group IIa (normal function), group IIb (restrictive ventilatory disturbances) and group IIc
(obstructive ventilatory disturbances). Spirometry was made before and after the
bronchoscopic procedure. Baseline hemoglobin saturation was compared to the lowest
level during the procedure.
Functional worsening caused by the procedure was observed with a decrease in forced vital
capacity (FVC), forced expiratory volume in the first second (FEV1) and Hemoglobin
saturation in all groups. Comparison between groups showed no significant difference
regarding the changes in FVC (P ¼ 0.8324), FEV1 (P ¼ 0.6952) and hemoglobin saturation
(P ¼ 0.5044).Elsevier Ltd. All rights reserved.
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Functional implications of BAL 1345We conclude that standardized BAL, like the one used in our study, does not result in an
increased risk for ventilatory impairment compared to bronchoscopy itself, independently
of the presence of previous respiratory disease.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Bronchoscopy is a safe and well-tolerated procedure with
diagnostic efficiency and low incidence of complications.
Some studies have reported an incidence of 0.09–1% of
major complications (bronchospasm, respiratory deteriora-
tion, syncope and arrhythmia), and a mortality rate from
0.001% to 0.1%, mainly associated with respiratory function
deterioration characterized by a decline in partial arterial
oxygen pressure (PaO2), or deterioration in forced vital
capacity (FVC) and forced expiratory volume in the first
second (FEV1).
1–6
For the analysis of functional deterioration, the effects of
bronchoscopy associated procedures (e.g., bronchoalveolar
lavage (BAL), biopsies, etc.) should be taken into account. A
mean frequency of 5% of BAL-related complications has been
reported, including fever, stertorous breathing upon lung
auscultation, transient radiologic infiltrate,7 bronchospasm,
and hypoxemia.8 However, a true separation between the
effects of bronchoscopy and those of BAL alone has not been
established.
Although there is international consensus regarding the
ideal technique for the execution of BAL,8–10 there is no
uniformity in its use (total volume infused, number of
aliquots, negative aspiration pressure, etc.). Technical
differences might influence the degree of functional
repercussions caused by BAL.
Most comparative studies determining the repercussions
of BAL have been conducted on individuals with normal
pulmonary function. Some investigators have emphasized
the existence of a higher risk in patients with impaired basal
function due to restrictive11,12 or obstructive diseases,
although some results are controversial.13–17 On the other
hand, these studies were made with interferent factors
(sedation, atropine, brochodilators, etc.) that difficult a
proper scrutinization of the results.
The aim of this study was to determine the additional
effects of BAL over the respiratory function deterioration
related to bronchoscopy in patients with different respira-
tory function profiles (normal, restrictive and obstructive).Patients and methods
We prospectively evaluated all patients referred for
diagnostic bronchoscopy in our service. Patients were
included in the study based on the following criteria:
agreement to participate in the study, performance of
baseline spirometry, absence of known or clinically sus-
pected pulmonary infections (bacterial or tuberculosis) and
absence of contraindications for bronchoscopy. Of all
patients submitted to bronchoscopy (more than 800 in a
period of 1 yr), 70 patients were initially included and
analyzed according to the following exclusion criteria:finding of an obstructive endobronchial lesion, diagnostic
or therapeutic procedures other than BAL performed during
the exam, presence of airway bleeding, abandonment of the
study and technically unacceptable initial or subsequent
spirometry results.18 On the basis of these exclusion criteria,
30 patients were excluded from the study. The population
thus selected consisted of 40 patients (22 men and 18
women).Spirometry
The spirometries were performed in a Collins GS System or in
a Koko Spirometer according to the recommendations of the
American Thoracic Society.18 After achievement of the
acceptability and reproducibility criteria, the highest FVC
and FEV1 values were recorded.
19–21
In all patients, the spirometric tests were performed
immediately before and at the end of bronchoscopic
examination. All patients were classified into different
functional groups defined on the basis of predicted values
for gender, age and height as described by Knudson et al.22
according to the criteria of the American Thoracic Society.Bronchoscopy
Bronchoscopy was performed by application of a topical
anesthetic (10% lidocaine spray) to the oropharynx. In order
to avoid interference no sedative or any other premedica-
tion was used. Topical anesthesia of the lower airways was
performed with 2% lidocaine. Throughout the exam patients
received continuous oxygen flow administered by nasal
catheter (3 L/min).23,24
The procedures were performed using flexible broncho-
scopes with an outer diameter of 4.9mm and an aspiration
channel of 2.2mm (Olympuss, models BF P20 and BF P30,
and Pentaxs, model FB 15X). Before BAL, all patients were
submitted to complete bilateral visual examination up to
the fifth order bronchi, at least.Bronchoalveolar lavage
BAL was performed according to the consensus of the
European Society of Pneumology.9 Saline solution was
injected in a total volume of 150mL, divided in three 50-
mL aliquots, at room temperature. After injection of each
sample, fluid was carefully aspirated using a collection
system coupled to a water column to control negative
pressure or a manual technique of mild aspiration with a
syringe coupled to the bronchoscope, with a limitation of
maximum negative pressure of 60mmHg.25 Forty to 75% of
the volume infused could be recovered from all patients.
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Table 1 Baseline clinical and functional data.
Group I Group IIa Group IIb Group IIc
Age (yr) 57 (22–70) 41 (18–78) 59 (27–65) 65 (48–76)
Gender (male/female) 5/5 6/4 4/6 7/3
FVC (L) 3.25 (2.11–5.04) 3.39 (2.51–5.70) 1.70 (0.93–3.59) 3.67 (2.11–4.23)
FVC (% of predicted) 118 (86–132) 110 (81–130) 56 (29–75) 94 (85–129)
FEV1 (L) 2.88 (1.57–3.86) 2.81 (1.79–4.95) 1.45 (0.79–2.93) 2.20 (1.79–2.97)
FEV1 (% of predicted) 114 (90–131) 110 (80–130) 55 (34–74) 72 (22–76)
Data are reported as median (min–max).
FVC ¼ forced vital capacity; FEV1 ¼ forced expiratory volume in the first second.
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W.L. Pedreira Jr. et al.1346Pulse oxymetry
Arterial hemoglobin oxygen saturation was measured with a
digital pulse oximeter (Dixtals, model Oxypleth Dx 2405)
from the beginning until the end of the exam. The baseline
and the lowest value during exam were recorded.-20
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Figure 1 Relative change in forced vital capacity after
bronchoscopy in the different groups. GI: bronchoscopy with
normal previous function; GIIa: bronchoscopy+BAL with normal
previous function; GIIb: bronchoscopy+BAL with restriction;
GIIc: bronchoscopy+BAL with obstruction.
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performance
Patients were classified based on the spirometry results and
performance or not of BAL into the following groups: group I,
patients sumitted to bronchoscopy only with normal
pulmonary function; group II, patients submitted to
bronchoscopy and BAL; these patients were then divided
into three subgroups based on the result of previous
spirometry: group Iia—normal spirometry, group Iib—res-
trictive ventilatory disturbance (FVCo80%, with a normal
FEV1/FVC ratio
26), and group Iic—obstructive ventilatory
disturbance (FEV1o75% of predicted and/or FEV1/FVC ratio
o70%, with previous history of obstructive symptoms).-10
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Figure 2 Relative change in forced expiratory volume in the
first second after bronchoscopy in the different groups. GI:
bronchoscopy with normal previous function; GIIa: bronchosco-
py+BAL with normal previous function; GIIb: bronchoscopy+BALStatistical analysis
The w2-test was used for analysis of the distribution of
patients in terms of gender and age in the different groups.
Intra and inter-group functional variations were analyzed by
the Friedman and Kruskal–Wallis tests, respectively The
Wilcoxon test was used for analysis of variation in
hemoglobin saturation. A P value lower than 0.05 was
considered to be significant in two-tailed tests.with restriction; GIIc: bronchoscopy+BAL with obstruction.Results
Baseline functional and clinical characteristics of all
patients are presented in Table 1 showing distincted
functional profiles among the different groups.
Bronchoscopy and BAL caused functional deterioration,
determined as a reduction in FVC and FEV1, in all groups.
Comparative analysis of the functional behavior triggered by
the procedures was similar in all groups with respect to FVC
(P ¼ 0.8324, Fig. 1) and FEV1 (P ¼ 0.6952, Fig. 2) after
bronchoscopy alone, or after bronchoscopy in combinationwith BAL, independently of the presence of ventilatory
disturbances.
Bronchoscopy caused a decrease in hemoglobin saturation
levels (percent variation) during the exam compared to
baseline values, with no significant difference (P ¼ 0.5044)
among the groups studied (Fig. 3).
None of the patients presented complications or required
interventions during or after the exam. The patients
remained under observation for 2 h after the procedures,
all of them being discharged thereafter.
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Figure 3 Change in hemoglobin oxygen saturation (SatO2) in
the different groups studied. GI: bronchoscopy with normal
previous function; GIIa: bronchoscopy+BAL with normal pre-
vious function; GIIb: bronchoscopy+BAL with restriction; GIIc:
bronchoscopy+BAL with obstruction.
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Our study showed that the functional impairment related to
bronchoscopy is not increased by the performance of BAL,
according to our protocol, and presented similar magnitude
in patients with or without previous ventilatory distur-
bances.
The exact causes that would explain functional deteriora-
tion triggered by bronchoscopy and BAL are still a matter of
controversy. Analysis of the mechanical effects of broncho-
scopy shows that the standard bronchoscope (outer dia-
meter of 4.9mm) occupies 10–15% of the tracheal lumen of
an adult, increasing airflow resistance,27 a fact suggesting
the occurrence of ventilatory disturbances caused by the
presence of the bronchoscope inside the airways.28 Another
mechanism that might explain functional deterioration is
the stimulation of local neuroreceptors probably in the
bronchial mucosa that leads to a vagus-mediated reflex,
causing bronchoconstriction. This theory would also explain
the beneficial effect of anticholinergic agents as premedica-
tion.29–31 Associated with this reflex, worsening of FEV1
might be related to direct lesion of the bronchial mucosa
accompanied by edema.
The question would be if those alterations are more
marked when BAL is used.23,32,33 The deleterious effects of
BAL could be associated with the filling of the bronchioles
with saline, collapse of alveolar spaces and distal bronch-
ioles, and the effect of surfactant dilution and removal. In
addition, a local effect is exerted on the bronchial mucosa
due to the heat exchange acting as a bronchoprovocation
(especially when BAL is performed with physiological saline
at room temperature),34 as well as the effects of aspiration
of the BAL fluid, which might cause trauma to the wall and
edema. However, our results showed that the performance
of BAL did not increase the deleterious functional effects of
bronchoscopy itself.
Both the European Respiratory Society and the American
Thoracic Society8,9 have published attempts to standardize
technical procedures for BAL, mainly approaching the
characteristics of the apparatus (diameter, aspiration
channel), lavage site, and total infused volume and aliquots
used. Interestingly, some results demonstrated no advan-
tage of infusate volumes higher than 150mL to obtain
adequate sampling of this alveolar space.35–38 Highervolumes have been related to worsening of pulmonary
function33 as excess negative pressure during aspiration of
BAL fluid (causing collapse of the airways, cell damage and
trauma to the wall with possible inflammation of the mucosa
and bleeding).9,39 In the present study, the parameters were
standardized for all exams: bronchoscope diameter of
4.9mm, maximum negative pressure of 60mmHg and a
total infusate volume of 150mL, with minimum recovery of
40%. The difference between the highest and the lowest
volume recovered was of 35mL, so that fluid recovery was
not a confounding variable in our study. This finding also
supports the assumption that although the negative pressure
was not controlled in all patients, airway collapse during the
recovery might not have been significant. Standardized
techniques may be related to a low incidence of side effects
of BAL, as seen in our study, although this specific hypothesis
remains to be addressed.
Our results confirm the deleterious effect of broncho-
scopy on pulmonary function in terms of spirometry and
hemoglobin saturation. We tried to establish the true
repercussions of flexible bronchoscopy itself on respiratory
function. For this purpose we excluded factors that could
interfere with this analysis, as the use of sedatives causing
hypoventilation, a fall in hemoglobin saturation and
hemodynamic disturbances.40,41 Previous studies analyzing
the effects of bronchoscopy and its associated procedures
are difficult to be compared due to the use of different
techniques and/or to the use of interfering
drugs.11–13,23,28,34,42–46
In the present study, patients submitted to bronchoscopy
alone had normal pulmonary function. In contrast to
previous results,13 we showed that even without interfering
factors related to premedication, bronchoscopy itself
caused worsening of pulmonary function. It would be of
major interest to address the behavior of small airways
during bronchoscopy and BAL, however the technical
limitations for this evaluation prevent a proper analysis.
Some have suggested that mid-expiratory flows would
represent the small airways, however the variability of this
measurement is too high for its routine use in clinical
practice therefore we have limited our analysis to FEV1 and
its relation to FVC. New techniques, as the electrical
impedance tomography, seem to be a nice perspective for
future studies about small airways.
Many studies have addressed the potential deleterious
effects of BAL over the pulmonary function. Decrease in
PaO2
47 and ventilation/perfusion disturbances23 have been
described. In contrast, other investigators34,48 obtained
data showing no impairment of pulmonary function. How-
ever, many factors could be involved in this discrepancy of
results, as the saline volume (80–1000mL), lavage tempera-
ture (room temperature or heated), aspiration pressure, the
use of sedatives or even the presence of previous respiratory
disturbances.
Reports of patients with restrictive ventilatory pattern
have shown effects ranging from small functional repercus-
sions49 to severe respiratory deterioration.11,12 Our results
showed that the magnitude of the functional impairment
related to bronchoscopy was not related to the presence of
restrictive ventilatory disturbance, even considering the
severity of the restrictive pattern shown in our group, with a
mean FVC of 52.7% of predicted value.
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obstructive lung disease is a matter of obvious concern,50,51
especially in patients with symptoms of bronchial hyper-
reactivity. Studies have shown functional deterioration and
desaturation, sometimes mild,28 sometimes more pro-
nounced,15,52 suggesting that this effect is potentiated by
BAL, especially when the procedure is performed at ambient
temperature.16,17 Some investigators have demonstrated
that these deleterious effects can be blocked by previous
administration of bronchodilators.13,51,53 We kept our
patients under observation up to 2 h after the procedure
(data not shown); pulmonary function and arterial oxygena-
tion presented progressive improvement towards baseline
values during this period without the need of bronchodila-
tors use, reinforcing the safety of bronchoscopy and BAL.
Our results confirm that some degree of functional
deterioration should be expected during bronchoscopy and
BAL54 and reinforces the assumption that the presence of
bronchospasm at the time of the exam should be regarded as
a contraindication for diagnostic bronchoscopy as long as
complete reversal of the symptoms is not obtained55.
Previous studies have shown that BAL may impair arterial
oxygenation.56 However, this effect may be related to a
number of BAL variables as the volume used and the
recovery rate. In our study, the behavior of hemoglobin
saturation in all groups showed that presence of previous
functional impairment or the performance of BAL did not
increase the deterioration in the oxygenation during
bronchoscopy. Nevertheless, the fact that hemoglobin
oxygen saturation was set to comfortable levels prior to
the exam through oxygen administration and that pulse
oxymetry was the chosen method to evaluate gas exchange,
with all the limitation regarding its sensitivity for detection
of mild impairments, have to be taken into consideration.
Even when considering individual cases of marked maximal
deterioration in saturation levels, all of them showed levels
of 90% or higher at the end of the exam.
It is of hallmark that standardized BAL was applied
throughout the study and certainly influenced the results.
Recently it has been demonstrated that the use of
standardized techniques during BAL may not only increase
diagnostic accurancy but also decrease side effects.57
The small sample size is certainly a limitation of our
study, preventing the extrapolation to less specific popula-
tions or to studies with different procedure protocols;
nevertheless, our results support that the standardized BAL
protocol used in our study had no additional effects over the
respiratory deterioration related to the bronchoscopy
procedure, even in patients with different ventilatory
profiles.
We conclude that as long as a patient meets the
conditions for the execution of bronchoscopy, standardized
BAL, like the one used in our study, does not result in an
increased risk for ventilatory impairment compared to
bronchoscopy itself, independently of the presence of
previous respiratory disease.Acknowledgment
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